no chance of a short squeeze until most or all of the below has occurred
- increase in sales and customer base from balama lowering $4m a month operational cost
- $150m operational loan confirmed for balama which will secure the business until this thing really kicks in mid 2026
- Tesla takes delivery of Vidalia AAM and firms up offtake hopefully all of the 11ktpa which will provide significant operating income
- Posco M firms up large offtake arrangement for Balama product sometime in 2025
- more signed off takes with 'multiple ' interested parties for Balama product which has been the communication from our business leader for 9 months now
gone are the days where this thing would fly on future earnings/ market potential pre 2020
however if I was short here , there is way more incentive to close now at current prices then to keep them open .all of the above could occur in the next 6 months .
Remember a credit raise was completed 6 months ago at double the SP!
Good luck all
- Forums
- ASX - By Stock
- SYR
- SYR: Short Squeeze Imminent
SYR
syrah resources limited
Add to My Watchlist
1.96%
!
26.0¢

SYR: Short Squeeze Imminent, page-163
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
26.0¢ |
Change
0.005(1.96%) |
Mkt cap ! $270.9M |
Open | High | Low | Value | Volume |
25.5¢ | 27.3¢ | 25.5¢ | $634.3K | 2.391M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 379430 | 26.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
26.5¢ | 40672 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 379430 | 0.260 |
10 | 264769 | 0.255 |
16 | 483863 | 0.250 |
13 | 503263 | 0.245 |
22 | 860417 | 0.240 |
Price($) | Vol. | No. |
---|---|---|
0.265 | 40672 | 5 |
0.270 | 144245 | 2 |
0.275 | 628178 | 11 |
0.280 | 177739 | 6 |
0.285 | 418600 | 6 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
SYR (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online